| Literature DB >> 36034360 |
Qiantong Dong1,2, Haonan Song2, Weizhe Chen3, Wenbin Wang2, Xiaojiao Ruan2, Tingting Xie2, Dongdong Huang2, Xiaolei Chen2, Chungen Xing1.
Abstract
Background: The impact of visceral obesity on the postoperative complications of colorectal cancer in elderly patients has not been well studied. This study aims to explore the influence of visceral obesity on surgical outcomes in elderly patients who have accepted a radical surgery for colorectal cancer.Entities:
Keywords: colorectal cancer; elderly patients; postoperative complication; risk factor; visceral obesity
Year: 2022 PMID: 36034360 PMCID: PMC9407030 DOI: 10.3389/fsurg.2022.827481
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Comparison of clinical characteristics between the VO group and the Non-VO group.
| Variables | Total ( | VO group ( | Non-VO group ( | |
|---|---|---|---|---|
| Age, mean (SD), years | 74.1 (6.2) | 74.0 ± 6.0 | 74.1 ± 6.4 | 0.913 |
| Gender | 0.001 | |||
| Male | 318 (60.2) | 138 (52.9) | 180 (67.4) | |
| Female | 210 (39.8) | 123 (47.1) | 87 (32.6) | |
| BMI, mean (SD), kg/m2 | 22.5 ± 3.1 | 24.2 ± 2.7 | 20.9 ± 2.5 | <0.001 |
| VFA, median (IQR), cm2 | 110.0 (90.0) | 157.2 (73.7) | 67.0 (54.7) | 0.001 |
| Albumin, mean (SD), g/L | 36.3 ± 4.4 | 36.7 ± 4.5 | 35.9 ± 4.3 | 0.039 |
| Hemoglobin, median (IQR), g/L | 118.5 (20) | 119 (20) | 116 (20) | 0.705 |
| ASA grade | 0.076 | |||
| I | 132 (25.0) | 48 (18.4) | 84 (31.5) | |
| II | 321 (60.8) | 182 (69.7) | 139 (52.1) | |
| III | 75 (14.2) | 31 (11.9) | 44 (16.5) | |
| NRS 2002 scores | 0.033 | |||
| ≥3 | 235 (44.5) | 104 (39.8) | 131 (49.1) | |
| <3 | 293 (55.5) | 157 (60.2) | 136 (50.9) | |
| Charlson comorbidity index | <0.001 | |||
| 0 | 222 (42.0) | 81 (31.0) | 141 (52.8) | |
| 1 | 198 (37.5) | 108 (41.4) | 90 (33.7) | |
| ≥2 | 108 (20.5) | 72 (27.6) | 36 (13.5) | |
| Previous abdominal surgery | 0.972 | |||
| Yes | 117 (22.2) | 58 (22.2) | 59 (22.2) | |
| No | 411 (77.8) | 203 (77.8) | 208 (77.9) | |
| Tumor location | 0.214 | |||
| Colon | 285 (54.0) | 148 (56.7) | 137 (51.3) | |
| Rectum | 243 (46.0) | 113 (43.3) | 130 (48.7) | |
| TNM stage | 0.041 | |||
| I | 96 (18.2) | 54 (20.7) | 42 (15.7) | |
| II | 219 (41.5) | 114 (43.7) | 105 (39.3) | |
| III | 195 (36.9) | 82 (31.4) | 113 (42.3) | |
| IV | 18 (3.4) | 11 (4.2) | 7 (2.6) | |
| Laparoscopy-assisted operation | 0.170 | |||
| Yes | 235 (44.5) | 124 (47.5) | 111 (41.6) | |
| No | 293 (55.5) | 137 (52.5) | 156 (58.4) | |
| Numbers of dissected lymph nodes, median (IQR) | 26 (5) | 25 (6) | 31 (5) | <0.001 |
| Lymph node positive | 194 (36.7) | 86 (33.0) | 108 (40.4) | 0.074 |
| Combined resection | 0.156 | |||
| Yes | 38 (7.2) | 23 (8.8) | 15 (5.6) | |
| No | 490 (92.8) | 238 (91.2) | 252 (94.4) |
Values in parentheses are percentages unless indicated otherwise.
SD, standard deviation; BMI, body mass index; VFA, visceral fat area; IQR, interquartile range; ASA, American Society of Anesthesiologists; NRS, nutritional risk screening; TNM, tumor–node–metastasis.
Charlson Comorbidity Index doesn’t consider points coming from cancer.
P < 0.05 was considered statistically significant.
Short-term outcomes.
| Factors | Total ( | VO group ( | Non-VO group ( | |
|---|---|---|---|---|
| Total complications | 137 (25.9) | 89 (34.1) | 48 (18.0) | <0.001 |
| Surgical complications | 107 (20.3) | 68 (26.1) | 39 (14.6) | 0.001 |
| Gastrointestinal dysfunction | 5 (0.9) | 3 (1.1) | 2 (0.7) | 0.980 |
| Wound infection | 29 (5.5) | 20 (7.7) | 9 (3.4) | 0.030 |
| Bleeding | 10 (1.9) | 4 (1.5) | 6 (2.2) | 0.777 |
| Intra-abdominal abscess | 27 (5.1) | 19 (7.3) | 8 (3.0) | 0.025 |
| Anastomotic leakage | 25 (4.7) | 16 (6.1) | 9 (3.4) | 0.136 |
| Intestinal obstruction | 11 (2.1) | 6 (2.3) | 5 (1.9) | 0.732 |
| Medical complications | 51 (9.7) | 33 (12.6) | 18 (6.7) | 0.022 |
| Pulmonary complications | 17 (3.2) | 13 (5.0) | 4 (1.5) | 0.023 |
| Cardiac complications | 3 (0.6) | 2 (0.8) | 1 (0.4) | 0.984 |
| Venous thrombosis | 9 (1.7) | 5 (1.9) | 4 (1.5) | 0.973 |
| Persistent hypoalbuminemia | 20 (3.8) | 12 (4.6) | 8 (3.0) | 0.335 |
| Urinary infection | 2 (0.4) | 1 (0.4) | 1 (0.4) | 1.000 |
| Reoperation for complications | 4 (0.8) | 1 (0.4) | 3 (1.1) | 0.632 |
| Stoma | 27 (5.1) | 9 (3.4) | 18 (6.7) | 0.086 |
| Surgical durations, median (IQR), minutes | 170 (84) | 180 (80) | 160 (85) | 0.002 |
| Postoperative hospital stays, median (IQR), days | 13 (7) | 13 (7.5) | 13 (6) | 0.583 |
| Costs, median (IQR), yuan | 54,892.3 (21,400.7) | 55,593.0 (23,085.8) | 53,753.7 (21,977.4) | 0.313 |
| Readmissions within 30 days of discharge | 25 (4.7) | 13 (5.0) | 12 (4.5) | 0.792 |
Values in parentheses are percentages unless indicated otherwise.
Including prolonged postoperative ileus and diarrhea.
P < 0.05 was considered statistically significant.
Univariate and multivariate logistic regression analysis of risk factors for total complications.
| Factors | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| Case with complication (%) |
| OR (95% CI) |
| |
| Age | 0.079 | |||
| ≥80/<80 | 38 (32.2)/99 (24.1) | |||
| Gender | 0.360 | |||
| Male/female | 78 (24.5)/59 (28.1) | |||
| BMI | 0.002 | |||
| <18.5 | 8 (16.3) | |||
| 18.5–24 | 73 (23.1) | |||
| > 24 | 56 (34.4) | |||
| Hypoalbuminemia | 0.034 | 1.692 (1.119–2.559) | 0.013 | |
| Yes/no | 56 (31.6)/81 (23.1) | |||
| Anemia | 0.565 | |||
| Yes/no | 55 (24.7)/82 (26.9) | |||
| NRS 2002 scores | 0.320 | |||
| ≥3/<3 | 56 (23.8)/81 (27.6) | |||
| ASA grade | 0.314 | |||
| III/II, I | 23 (30.7)/114 (25.2) | |||
| Charlson comorbidity index | 0.107 | |||
| 0 | 51 (23.0) | |||
| 1 | 52 (26.3) | |||
| ≥2 | 34 (31.5) | |||
| Visceral obesity | <0.001 | 2.482 (1.649–3.737) | <0.001 | |
| Yes/no | 89 (34.1)/48 (18.0) | |||
| Previous abdominal surgery | 0.422 | |||
| Yes/no | 27 (23.1)/110 (26.8) | |||
| Tumor location | 0.850 | |||
| Colon/rectum | 73 (25.6)/64 (26.3) | |||
| TNM stage | 0.686 | |||
| I | 25 (26.0) | |||
| II | 54 (24.7) | |||
| III, IV | 58 (27.2) | |||
| Combined resection | 0.411 | |||
| Yes/no | 12 (31.6)/125 (25.5) | |||
| Laparoscopic-assisted surgery | 0.111 | |||
| Yes/no | 53 (22.6)/84 (28.7) | |||
OR, Odds Ratio; CI, Confidence Interval; BMI, Body mass index; ASA, American Society of Anesthesiologists; TNM, tumor–node–metastasis.
Statistically significant (P < 0.05).
Univariate and multivariate logistic regression analysis of risk factors for surgical complications.
| Factors | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| Case with complication (%) |
| OR (95% CI) |
| |
| Age | 0.114 | |||
| ≥80/<80 | 30 (25.4)/77 (18.8) | |||
| Gender | 0.100 | |||
| Male/female | 57 (17.9)/50 (23.8) | |||
| BMI | 0.080 | |||
| <18.5 | 6 (12.2) | |||
| 18.5–24 | 62 (19.6) | |||
| > 24 | 39 (23.9) | |||
| Hypoalbuminemia | 0.239 | |||
| Yes/no | 41 (23.2)/66 (18.8) | |||
| Anemia | 0.358 | |||
| Yes/no | 41 (18.4)/66 (21.6) | |||
| NRS 2002 scores | 0.568 | |||
| ≥3/<3 | 45 (19.1)/62 (21.2) | |||
| ASA grade | 0.804 | |||
| III/II, I | 16 (21.3)/91 (20.1) | |||
| Charlson comorbidity index | 0.379 | |||
| 0 | 41 (18.5) | |||
| 1 | 42 (21.2) | |||
| ≥2 | 24 (22.2) | |||
| Visceral obesity | 0.001 | 2.060 (1.329–3.191) | 0.001 | |
| Yes/no | 68 (26.1)/39 (14.6) | |||
| Previous abdominal surgery | 0.333 | |||
| Yes/no | 20 (17.1)/87 (21.2) | |||
| Tumor location | 0.703 | |||
| Colon/rectum | 56 (19.6)/51 (21.0) | |||
| TNM stage | 0.720 | |||
| I | 19 (19.8) | |||
| II | 43 (19.6) | |||
| III, IV | 45 (21.1) | |||
| Combined resection | 0.167 | |||
| Yes/no | 11 (28.9)/96 (19.6) | |||
| Laparoscopic-assisted surgery | 0.568 | |||
| Yes/no | 45 (19.1)/62 (21.2) | |||
OR, Odds Ratio; CI, Confidence Interval; BMI, Body mass index; ASA, American Society of Anesthesiologists; TNM, tumor–node–metastasis.
Statistically significant (P < 0.05).
Univariate and multivariate logistic regression analysis of risk factors for medical complications.
| Factors | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| Case with complication (%) |
| OR (95% CI) |
| |
| Age | 0.104 | |||
| ≥80/<80 | 16 (13.6)/35 (8.5) | |||
| Gender | 0.932 | |||
| Male/female | 31 (9.7)/20 (9.5) | |||
| BMI | 0.022 | |||
| <18.5 | 3 (6.1) | |||
| 18.5–24 | 25 (7.9) | |||
| >24 | 23 (14.1) | |||
| Hypoalbuminemia | 0.014 | 2.206 (1.224–3.977) | 0.008 | |
| Yes/no | 25 (14.1)/26 (7.4) | |||
| Anemia | 0.463 | |||
| Yes/no | 24 (10.8)/27 (8.9) | |||
| NRS 2002 scores | 0.615 | |||
| ≥3/< | 21 (8.9)/30 (10.2) | |||
| ASA grade | 0.113 | |||
| III/II, I | 11 (14.7)/40 (8.8) | |||
| Charlson comorbidity index | 0.156 | |||
| 0 | 19 (8.6) | |||
| 1 | 16 (8.1) | |||
| ≥2 | 16 (14.8) | |||
| Visceral obesity | 0.022 | 2.150 (1.170–3.953) | 0.014 | |
| Yes/no | 33 (12.6)/18 (6.7) | |||
| Previous abdominal surgery | 0.414 | |||
| Yes/no | 9 (7.7)/42 (10.2) | |||
| Tumor location | 0.876 | |||
| Colon/rectum | 27 (9.5)/24 (9.9) | |||
| TNM stage | 0.327 | |||
| I | 8 (8.3) | |||
| II | 19 (8.7) | |||
| III, IV | 24 (11.3) | |||
| Combined resection | 0.636 | |||
| Yes/no | 5 (13.2)/46 (9.4) | |||
| Laparoscopic-assisted surgery | 0.047 | |||
| Yes/no | 16 (6.8)/35 (11.9) | |||
OR, Odds Ratio; CI, Confidence Interval; BMI, Body mass index; ASA, American Society of Anesthesiologists; TNM, tumor–node–metastasis.
Statistically significant (P < 0.05).